Valuation
- Market cap
- —
- Revenue TTM
- $34,070,000
- Net income TTM
- $-20,130,000
- PE ratio
- —
- Forward PE
- —
- Profit margin
- —
- Debt to equity
- —
Trading
- Volume
- 4,300
- Avg volume
- 8,254
- Day's range
- $0.03 – $0.03
- Shares out
- —
- Stochastic %K
- 89%
- Beta
- —
- Analysts
- Strong Sell
- Price target
- —
Company profile
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massac...
Show more
Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. It offers Ameluz, BF-RhodoLED, RhodoLED XL lamp series, and RhodoLED Lamps, which are used for the treatment of actinic keratosis, which are pre-cancerous skin lesions. The company was incorporated in 2015 and is headquartered in Woburn, Massachusetts.
- Phone
- 781 245 1325
- Website
- https://www.biofrontera-us.com
- Address
- 660 Main Street, 1st Floor, Woburn, United States
Latest news
No headlines yet.
